Sort
21,281 grants matching “influenza”
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$690,485Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Prostate Cancer Immunotherapy
$690,294Rockefeller University · R01 · FY2005 · CA
Site Development for Emerging Diseases and Biodefense
$690,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2012 · AI
Robust, defined, animal-free cell culture medium for the production of vaccines
$689,933Steve Clyde Pettit · Ventria Bioscience · R44 · FY2012 · AI
Replication of influenza virus
$689,912Robert M Krug · University Of Texas At Austin · R01 · FY2012 · AI
Linking SARS-CoV-2 Aerosol Viability and Environmental Factors in Healthcare Settings
$689,610Kerry Kelly · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
Analysis of breakthrough influenza infections to identify viral and immunological markers of vaccine failure
$689,374National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$689,042Harvinder Singh Gill · Texas Tech University · R01 · FY2021 · AI
Novel Combination Adjuvant for Eliciting Systemic and Mucosal CD8 T Cell Memory
$689,029Marulasiddappa Suresh · University Of Wisconsin-Madison · U01 · FY2020 · AI
Studies of IGHV Germline Gene Polymorphism, Utilization & Shifting for Seasonal Influenza Vaccine Induced Broadly Neutralizing Antibody Responses
$688,901Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2020 · AI
Immunomodulation for Heart Allograft Tolerance
$688,794Richard N Pierson · University Of Maryland Baltimore · U01 · FY2008 · AI
Community - based behavioral intervention to increase COVID - 19 and influenza vaccination for African American/ Black and Latino persons: An optimization randomized controlled trial
$688,573Marya Gwadz · New York University · R01 · FY2024 · MD
Systems Immunology
$688,458John S Tsang · University Of Maryland Baltimore · U19 · FY2024 · AI
Engineered âmuco-trappingâ antibodies for inhaled therapy of parainfluenza and human metapneumovirus infections
$688,413Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Mechanism and Inhibition of Thogotovirus Entry
$688,397Adrianus Cm Boon · Washington University · R01 · FY2024 · AI
Engineered âmuco-trappingâ antibodies for inhaled therapy of parainfluenza and human metapneumovirus infections
$688,330Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
mRNA-encoded Cas13 as a pan-respiratory antiviral
$688,094Philip J Santangelo · Emory University · R01 · FY2025 · AI
Cell Based Immunomodulation to Suppress Lung Inflammation and Promote Repair
$687,727Ravi K Ghanta · Baylor College Of Medicine · R01 · FY2025 · HL
HIV, gestational diabetes and TB in pregnancy
$687,723Jyoti S Mathad · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Genetic Markers of Long-Term Mumps Vaccine Immunity
$687,634Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2020 · AI
Influence of the nasal microbiome on host susceptibility and response to respiratory viruses
$687,599Cindy Liu · George Washington University · R01 · FY2025 · AI
The effect of childhood environments on adult health and mortality
$687,535Dahai Yue · Univ Of Maryland, College Park · R01 · FY2025 · AG
Microneedle-based immunization against pandemic influenza
$687,516Mark R Prausnitz · Georgia Institute Of Technology · R01 · FY2010 · EB
Neisserial porins and antigen presenting cells
$687,504Lee Mark Wetzler · Boston Medical Center · R01 · FY2019 · AI
Neisserial porins and antigen presenting cells
$687,504Lee Mark Wetzler · Boston Medical Center · R01 · FY2018 · AI